生命科学资讯
生物技术与制药领域的最新动态
Helus Pharma's stock slides after psychedelic drug data face questions over dosing
New FDA bonus pilot to address 'workforce challenges'
Eli Lilly's new program aims to boost employer coverage of GLP-1s
Tenaya wins support from Alnylam in cardio disease pact
旧金山健康人工智能快讯
Health AI dispatch from SF
中国挑战全球十大最昂贵药品
China is taking on the world’s 10 most expensive medicines
默克集团放弃SpringWorks交易中两项癌症试验资产。
Merck KGaA drops two cancer trials on assets from SpringWorks deal
诺和诺德详述爱尔兰扩张计划;EuroAPI的挑战持续存在
Novo Nordisk details Irish expansion; EuroAPI’s challenges continue
医院如何从AI实验转向成本合理化
How hospitals have shifted from experimenting with AI to justifying its cost
耶鲁大学克雷格·克鲁斯构建模型,助力生物科技初创企业跨越学术“死亡谷”。
Yale’s Craig Crews builds model to guide biotech startups out of academia’s ‘valley of death’
美国食药监局首席运营官巴特勒将退休,副手将于四月接任。
FDA's top operating official Butler to retire, deputy to take over in April
拜耳继续裁员;AnaptysBio分拆公司命名
Bayer continues trimming workforce; AnaptysBio's spinoff is named
BIO主席仍支持FDA的马卡里,尽管其决策令人费解。
BIO chief still backs FDA's Makary despite 'head-scratcher' decisions
赛诺菲以1.35亿美元预付款获中国生物制药移植药物许可。
Sanofi licenses Sino Biopharm’s transplant drug for $135M upfront
UCB以6000万美元预付款与Antengene达成T细胞衔接器合作协议。
UCB boards T cell engager train in $60M upfront deal with Antengene
黑石集团以4亿美元支持梯瓦制药与赛诺菲合作的TL1A项目。
Blackstone to support Teva on Sanofi-partnered TL1A with $400M
Moderna斥资9.5亿美元与Arbutus及Roivant达成新冠疫苗专利索赔和解。
Moderna will pay $950M to settle Covid vaccine patent claims with Arbutus, Roivant
传统医疗行业正逐步拥抱科技。
Old school healthcare is warming up to tech
Prime Medicine改变策略,寻求FDA批准曾被搁置的疗法。
Prime Medicine reverses course to seek FDA approval of shelved therapy